Product Information

AMIODARONE HCL 200 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.1206 per EA under NDC 72888003960. Its NADAC has been published 267 times since Jul 14, 2021.

FDA first approved this application on Nov 6, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMIODARONE HCL 200 MG TABLET

Amiodarone Hydrochloride
$0.1206per EA

Strength

200 mg/1

NDC

72888003960

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

AMIODARONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078578

FDA Approved

11/6/2008

TE Code

AB

On Market Since

3/9/2020

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for AMIODARONE HCL 200 MG TABLET has been published 267 times since Jul 14, 2021, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1206 per EA
All-time high$0.1436 (Aug 11, 2021)
All-time low$0.0989 (Nov 20, 2024)
52-week high$0.1227
52-week low$0.1160
Median price$0.1203
Average price$0.1195
Largest weekly change-17.6% (Apr 17, 2024)
Weeks tracked267
Tracking sinceJul 14, 2021

Price History

1W

+1.3%

1M

+1.3%

3M

+1.4%

6M

-0.5%

1Y

+2.5%

3Y

-1.1%

5Y

-12.0%

All

-13.2%

Generic Alternatives

The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMIODARONE HCL 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 200 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.1206 per EA (NDC 72888003960), effective Aug 19, 2026.

How has the price of AMIODARONE HCL 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for AMIODARONE HCL 200 MG TABLET has declined 13.2%. It has been tracked across 267 weekly CMS publications since Jul 14, 2021.

What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 200 MG TABLET?

Since Jul 14, 2021, the NADAC for AMIODARONE HCL 200 MG TABLET has ranged from a low of $0.0989 (Nov 20, 2024) to a high of $0.1436 (Aug 11, 2021), with a median of $0.1203 per EA.

Are there cheaper alternatives to AMIODARONE HCL 200 MG TABLET?

9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMIODARONE HCL 200 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures AMIODARONE HCL 200 MG TABLET?

AMIODARONE HCL 200 MG TABLET (NDC 72888003960) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.